4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-019006
Chief Executive Officer gave up 2,941 shares (to pay taxes)
- Chief Executive Officer acquired 62,440 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hardy Alexander · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-13 | Shares withheld for taxes : show line 1 in the form | −2,941 | $58.51 | $172,078 | 156,447 | D |
| 2026-03-16 | Grant or award : show line 2 in the form | +62,440 | 218,887 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-16 | Grant or award : show line 3 in the form Stock Option (Right to Buy Common Stock) | +89,200 | 89,200 | D |
Loading xslF345X05/wk-form4_1773794583.xml…